Skip to main content

Table 1 Comparison of clinico-pathological characteristics among the 4 groups of treatment modality

From: Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

Variable (continuous)

 

Kruskal-Wallis ANOVA by Ranks test (Median test) Mean ± SD

P-value

Age

A SEMS

B Chemo

C Radiation

D C/R

69.57 ± 10.08

P = 0.017 (SEMS vs. C/R* P = 0.013)

  

67.00 ± 4.30

 
  

66.44 ± 8.57

 
  

61.05 ± 9.74

 

BMI

 

24.87 ± 4.27

P = 0.466

  

25.91 ± 5.65

 
  

25.70 ± 4.00

 
  

24.81 ± 5.11

 

Vital capacity (VC)

 

3.54 ± 1.08

P = 0.287

  

3.75 ± 0.93

 
  

2.75 ± 1.28

 
  

3.78 ± 0.95

 

FEV 1

 

32.53 ± 33.53

P = 0.306

  

41.29 ± 33.42

 
  

38.86 ± 30.13

 
  

46.98 ± 28.11

 

Variable (categorical)

Distribution of variable categories among groups of therapy

Spearman Rank Order Correlations

P -value

cTNM-classification

 

-0.124360

0.165

ASA-classification

 

-0.017661

0.876

Nutrition

 

0.166002

0.244

Smoking

 

0.080980

0.387

Alcohol

 

0.082105

0.380

Child-Pugh score

 

0.033203

0.724

Pulmonary status

 

0.226517

0.013

Cardiovascular status

 

-0.226854

0.013

Diabetes

 

-0.043337

0.642

Secondary carcinoma

 

0.095611

0.286

Gender

 

-0.146058

0.095

Histology

 

-0.348704

0.001

Localization

 

-0.259496

0.002

Contraindications for surgery

 

0.032170

0.715

Causes of inoperability

 

0.128822

0.142

Site of metastases

 

-0.060909

0.566

Type of metastases

 

0.224707

0.032

  1. SD: Standard deviation; SEMS: Self-expandable metallic stents; C/R*: Chemo-Radiotherapy; BMI: body mass index; ASA: American Society of Anesthesiologists classification; FEV 1 : Forced expiratory volume in 1 s